Kneeling tolerance when using quadriceps tendon autograft for anterior cruciate ligament reconstruction is superior to hamstring tendon autograft

医学 跪着 骨科手术 股四头肌肌腱 前交叉韧带重建术 前交叉韧带 腿筋拉伤 肌腱 外科 病理 替代医学
作者
Nicholas Calvert,Jay R. Ebert,Ross Radic
出处
期刊:Knee Surgery, Sports Traumatology, Arthroscopy [Springer Science+Business Media]
卷期号:33 (7): 2390-2396
标识
DOI:10.1002/ksa.12583
摘要

Abstract Purpose To investigate kneeling tolerance in patients undergoing hamstring (HT) versus quadriceps (QT) anterior cruciate ligament reconstruction (ACLR) and investigate correlation with patient‐reported outcome measures (PROMs). Methods After recruitment and randomisation, 112 patients (HT = 55; QT = 57) underwent ACLR. Patients were assessed at 6, 12 and 24 months using the Kneeling Tolerance Test, which evaluates patient‐reported pain in a position of both 90 (KT90) and 110 (KT110) degrees of knee flexion. PROMs collected included the International Knee Documentation Committee (IKDC) questionnaire and the ACL Return to Sport after Injury (ACL‐RSI) questionnaire. Results Kneeling tolerance at KT90 and KT110 improved ( p < 0.05) for both graft types across all time points. There was no difference in KT90 scores between groups at 6 or 12 months. At 24 months, kneeling tolerance was superior in the QT group (mean HT 93 ± 9 vs. QT 98 ± 5; p = 0.003). For KT110 scores, a statistically significant difference was noted at 6 (mean HT 80 ± 25 vs. QT 89 ± 12; p = 0.027), 12 (mean HT 90 ± 13 vs. QT 95 ± 10; p = 0.040) and 24 months (mean HT 92 ± 10 vs. QT 97 ± 5; p = 0.003). The ACL‐RSI was significantly correlated with KT90 and KT110 at 24 months ( r = 0.40, p < 0.001; r = 0.40, p < 0.001). Other PROMs demonstrated significant weak‐to‐moderate correlations with kneeling tolerance. Conclusion Patients undergoing ACLR with a QT versus HT autograft report superior kneeling tolerance up to 2 years postsurgery, more prominent in deeper (110°) knee flexion. A strong correlation with ACL‐RSI was demonstrated at 2 years. Registration ACTRN12618001520224p (Australian New Zealand Clinical Trials Registry). Level of Evidence Level 1.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
科研通AI6.2的应助被俊逸蓝血采纳,获得10
1秒前
层层泡芙完成签到,获得积分10
1秒前
1秒前
panswiii发布了新的文献求助10
2秒前
Akim的应助被爱撒娇的妙竹采纳,获得30
2秒前
科研通AI6.4的应助被田小冉采纳,获得10
2秒前
adasdad完成签到 ,获得积分10
2秒前
柳慧发布了新的文献求助10
3秒前
初景发布了新的文献求助80
3秒前
晓云关注了科研通微信公众号
4秒前
leeee完成签到,获得积分10
4秒前
5秒前
5秒前
隐形曼青的应助被云栈出谷采纳,获得10
5秒前
研友_VZG7GZ的应助被青冥之外采纳,获得10
5秒前
6秒前
6秒前
柔弱的小甜瓜完成签到,获得积分10
7秒前
9秒前
烟花的应助被CC采纳,获得10
9秒前
MAK完成签到,获得积分10
9秒前
10秒前
朱佳慧发布了新的文献求助10
10秒前
BIN完成签到,获得积分10
10秒前
科研通AI6.4的应助被feicui369采纳,获得10
10秒前
bby发布了新的文献求助10
11秒前
11秒前
molihuakai的应助被没好品德采纳,获得10
12秒前
molihuakai的应助被柳慧采纳,获得10
12秒前
斯文败类的应助被柳慧采纳,获得10
12秒前
研友_VZG7GZ的应助被chenjun7080采纳,获得10
13秒前
Cauchy完成签到,获得积分10
14秒前
KID完成签到,获得积分10
14秒前
香蕉觅云的应助被xx采纳,获得10
15秒前
15秒前
15秒前
可爱的函函的应助被llssmm采纳,获得10
15秒前
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
CODESSA Version 2.13 for Windows 2000
Agricultural Ecology (Liao Yuncheng & Lin Wenxiong) 1000
Rosenblum, Global Change Biology 800
Berberine regulates the TLR4 signaling pathway to suppress hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells 520
Organizational Behavior 510
Derham on the Law of Set Off (德勒姆论抵消法/第五版) 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 有机化学 化学工程 内科学 物理 生物化学 复合材料 催化作用 细胞生物学 人工智能 心理学 无机化学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 7846163
求助须知:如何正确求助?哪些是违规求助? 9366346
关于积分的说明 20649862
捐赠科研通 7442167
什么是DOI,文献DOI怎么找? 3341588
关于科研通互助平台的介绍 2485444
邀请新用户注册赠送积分活动 2364127